Description
Tirzepatide is a synthetic peptide consisting of 39 amino acids. It represents a breakthrough in metabolic research as a first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This specific co-agonism is being widely investigated in laboratory settings for its synergistic effects on insulin secretion, glucose-dependent glucagon suppression, and metabolic homeostasis.
Key Research Specifications:
-
Molecular Formula: C_{225}H_{348}N_{48}O_{68}
-
Purity: ≥99% (HPLC verified)
-
Format: Lyophilized white powder
-
Stability: Optimized for structural integrity during prolonged analytical evaluation.
Research Applications:
-
Investigation into dual-agonist signaling in GIP and GLP-1 receptor pathways.
-
Studies on the regulation of pancreatic beta-cell function and insulin sensitivity.
-
Research regarding the impact of dual-incretin mimetics on adipose tissue and metabolic rate.
Disclaimer: This product is intended for laboratory research and analytical purposes only. It is NOT for human consumption, veterinary use, or any form of clinical application. All purchasers must be qualified researchers.
Reviews
There are no reviews yet